日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomimetic peptide conjugates as emerging strategies for controlled release from protein-based materials

仿生肽缀合物作为蛋白质基材料可控释放的新兴策略

Manissorn, Juthatip; Promsuk, Jaturong; Wangkanont, Kittikhun; Thongnuek, Peerapat

Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes

松属素与药物转运蛋白和肝脏药物代谢酶的潜在相互作用

Sangkapat, Sirima; Boonnop, Rattiporn; Pimta, Jeerawat; Chabang, Napason; Nutho, Bodee; Jutabha, Promsuk; Soodvilai, Sunhapas

Optimization of carbon capture and storage transportation networks in Thailand using the artificial hummingbird algorithm

利用人工蜂鸟算法优化泰国碳捕获与封存运输网络

Promsuk, Natthanan; Daraneesrisuk, Jirawat; Thongrueang, Nutnaree; Suetrong, Nopparuj

Optimizing protein delivery rate from silk fibroin hydrogel using silk fibroin-mimetic peptides conjugation

利用丝素蛋白模拟肽偶联优化丝素蛋白水凝胶的蛋白质递送速率

Promsuk, Jaturong; Manissorn, Juthatip; Laomeephol, Chavee; Luckanagul, Jittima Amie; Methachittipan, Apipon; Tonsomboon, Khaow; Jenjob, Ratchapol; Yang, Su-Geun; Thongnuek, Peerapat; Wangkanont, Kittikhun

Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels

SLC22A12基因罕见变异对血清尿酸水平遗传性缺失的贡献

Misawa, Kazuharu; Hasegawa, Takanori; Mishima, Eikan; Jutabha, Promsuk; Ouchi, Motoshi; Kojima, Kaname; Kawai, Yosuke; Matsuo, Masafumi; Anzai, Naohiko; Nagasaki, Masao

Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin

SGLT2抑制剂托格列净降低尿酸水平与HbA1c降低的关系

Ouchi, Motoshi; Oba, Kenzo; Kaku, Kohei; Suganami, Hideki; Yoshida, Akihiro; Fukunaka, Yasunori; Jutabha, Promsuk; Morita, Asuka; Otani, Naoyuki; Hayashi, Keitaro; Fujita, Tomoe; Suzuki, Tatsuya; Yasutake, Masahiro; Anzai, Naohiko

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion

α-葡萄糖苷酶抑制剂米格列醇对SGLT3、肠内分泌细胞和GLP-1分泌的独特作用

Lee, Eun Young; Kaneko, Shuji; Jutabha, Promsuk; Zhang, Xilin; Seino, Susumu; Jomori, Takahito; Anzai, Naohiko; Miki, Takashi

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies

强效人尿酸转运蛋白1抑制剂:体外和体内代谢及药代动力学研究

Wempe, Michael F; Lightner, Janet W; Miller, Bettina; Iwen, Timothy J; Rice, Peter J; Wakui, Shin; Anzai, Naohiko; Jutabha, Promsuk; Endou, Hitoshi

Developing potent human uric acid transporter 1 (hURAT1) inhibitors

开发有效的人类尿酸转运蛋白 1 (hURAT1) 抑制剂

Michael F Wempe, Promsuk Jutabha, Bettina Quade, Timothy J Iwen, Morin M Frick, Ian R Ross, Peter J Rice, Naohiko Anzai, Hitoshi Endou

A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules

SLC22家族的一种新型转运蛋白特异性地转运前列腺素,并与肾近端小管中的15-羟基前列腺素脱氢酶共定位。

Katsuko Shiraya,Taku Hirata, Ryo Hatano, Shushi Nagamori, Pattama Wiriyasermkul, Promsuk Jutabha, Mitsunobu Matsubara, Shigeaki Muto, Hidekazu Tanaka, Shinji Asano, Naohiko Anzai, Hitoshi Endou, Akira Yamada, Hiroyuki Sakurai, Yoshikatsu Kanai